Request Sample Inquiry
in Vitro Diagnostics (ivd) Market

In vitro Diagnostics (IVD) Market

In vitro Diagnostics (IVD) Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

149

Base Year:

2022

Date

Dec - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1938

Segments Covered
  • By Products & Services By Products & Services Reagents & Kits, Instruments, Services, Data Management Software
  • By Technology By Technology Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Other Technologies
  • By Application By Application Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, HIV/AIDS, Nephrology, Other Applications
  • By End User By End User Hospital Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, Other End Users
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 112.64 Billion
Revenue 2030Revenue 2030: USD 157.75 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 4.30%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global In vitro Diagnostics (IVD) Market - Segment Analysis
    1. Overview
    2. Global In vitro Diagnostics (IVD) Market, 2016 - 2028 (USD Million)
    3. Global In vitro Diagnostics (IVD) Market - by Products & Services
      1. By Reagents & Kits
      2. By Instruments
      3. By Services
      4. By Data Management Software
    4. Global In vitro Diagnostics (IVD) Market - by Technology
      1. By Immunoassay/ Immunochemistry
      2. By Clinical Chemistry
      3. By Molecular Diagnostics
      4. By Hematology
      5. By Microbiology
      6. By Coagulation & Hemostasis
      7. By Urinalysis
      8. By Other Technologies
    5. Global In vitro Diagnostics (IVD) Market - by Application
      1. By Infectious Diseases
      2. By Diabetes
      3. By Oncology
      4. By Cardiology
      5. By Drug Testing/ Pharmacogenomics
      6. By Autoimmune Diseases
      7. By HIV/AIDS
      8. By Nephrology
      9. By Other Applications
    6. Global In vitro Diagnostics (IVD) Market - by End User
      1. By Hospital Laboratories
      2. By Clinical Laboratories
      3. By Point-of-care Testing Centers
      4. By Academic Institutes
      5. By Patients
      6. By Other End Users
    7. Global In vitro Diagnostics (IVD) Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America In vitro Diagnostics (IVD) Market - Segment Analysis
    1. Overview
    2. North America In vitro Diagnostics (IVD) Market, 2016 - 2028 (USD Million)
    3. North America In vitro Diagnostics (IVD) Market, by Products & Services
      1. By Reagents & Kits
      2. By Instruments
      3. By Services
      4. By Data Management Software
    4. North America In vitro Diagnostics (IVD) Market, by Technology
      1. By Immunoassay/ Immunochemistry
      2. By Clinical Chemistry
      3. By Molecular Diagnostics
      4. By Hematology
      5. By Microbiology
      6. By Coagulation & Hemostasis
      7. By Urinalysis
      8. By Other Technologies
    5. North America In vitro Diagnostics (IVD) Market, by Application
      1. By Infectious Diseases
      2. By Diabetes
      3. By Oncology
      4. By Cardiology
      5. By Drug Testing/ Pharmacogenomics
      6. By Autoimmune Diseases
      7. By HIV/AIDS
      8. By Nephrology
      9. By Other Applications
    6. North America In vitro Diagnostics (IVD) Market, by End User
      1. By Hospital Laboratories
      2. By Clinical Laboratories
      3. By Point-of-care Testing Centers
      4. By Academic Institutes
      5. By Patients
      6. By Other End Users
    7. North America In vitro Diagnostics (IVD) Market, by Country
      1. U.S.
        1. U.S. In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. U.S. In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. U.S. In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. U.S. In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      2. Canada
        1. Canada In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Canada In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Canada In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Canada In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      3. Mexico
        1. Mexico In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Mexico In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Mexico In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Mexico In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
  5. Europe In vitro Diagnostics (IVD) Market - Segment Analysis
    1. Overview
    2. Europe In vitro Diagnostics (IVD) Market, 2016 - 2028 (USD Million)
    3. Europe In vitro Diagnostics (IVD) Market, by Products & Services
      1. By Reagents & Kits
      2. By Instruments
      3. By Services
      4. By Data Management Software
    4. Europe In vitro Diagnostics (IVD) Market, by Technology
      1. By Immunoassay/ Immunochemistry
      2. By Clinical Chemistry
      3. By Molecular Diagnostics
      4. By Hematology
      5. By Microbiology
      6. By Coagulation & Hemostasis
      7. By Urinalysis
      8. By Other Technologies
    5. Europe In vitro Diagnostics (IVD) Market, by Application
      1. By Infectious Diseases
      2. By Diabetes
      3. By Oncology
      4. By Cardiology
      5. By Drug Testing/ Pharmacogenomics
      6. By Autoimmune Diseases
      7. By HIV/AIDS
      8. By Nephrology
      9. By Other Applications
    6. Europe In vitro Diagnostics (IVD) Market, by End User
      1. By Hospital Laboratories
      2. By Clinical Laboratories
      3. By Point-of-care Testing Centers
      4. By Academic Institutes
      5. By Patients
      6. By Other End Users
    7. Europe In vitro Diagnostics (IVD) Market, by Country
      1. Germany
        1. Germany In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Germany In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Germany In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Germany In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      2. UK
        1. UK Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. UK Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. UK Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. UK Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      3. France
        1. France In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. France In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. France In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. France In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      4. Spain
        1. Spain In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Spain In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Spain In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Spain In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      5. Italy
        1. Italy In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Italy In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Italy In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Italy In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      6. BENELUX
        1. BENELUX In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. BENELUX In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. BENELUX In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. BENELUX In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      7. Rest of Europe
        1. Rest Of Europe In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Rest Of Europe In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Rest Of Europe In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Rest Of Europe In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
  6. Asia Pacific In vitro Diagnostics (IVD) Market - Segment Analysis
    1. Overview
    2. Asia Pacific In vitro Diagnostics (IVD) Market, 2016 - 2028 (USD Million)
    3. Asia Pacific In vitro Diagnostics (IVD) Market, by Products & Services
      1. By Reagents & Kits
      2. By Instruments
      3. By Services
      4. By Data Management Software
    4. Asia Pacific In vitro Diagnostics (IVD) Market, by Technology
      1. By Immunoassay/ Immunochemistry
      2. By Clinical Chemistry
      3. By Molecular Diagnostics
      4. By Hematology
      5. By Microbiology
      6. By Coagulation & Hemostasis
      7. By Urinalysis
      8. By Other Technologies
    5. Asia Pacific In vitro Diagnostics (IVD) Market, by Application
      1. By Infectious Diseases
      2. By Diabetes
      3. By Oncology
      4. By Cardiology
      5. By Drug Testing/ Pharmacogenomics
      6. By Autoimmune Diseases
      7. By HIV/AIDS
      8. By Nephrology
      9. By Other Applications
    6. Asia Pacific In vitro Diagnostics (IVD) Market, by End User
      1. By Hospital Laboratories
      2. By Clinical Laboratories
      3. By Point-of-care Testing Centers
      4. By Academic Institutes
      5. By Patients
      6. By Other End Users
    7. Asia Pacific In vitro Diagnostics (IVD) Market, by Country
      1. China
        1. China In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. China In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. China In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. China In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      2. Japan
        1. Japan In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Japan In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Japan In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Japan In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      3. India
        1. India In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. India In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. India In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. India In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      4. South Korea
        1. South Korea In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. South Korea In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. South Korea In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. South Korea In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      5. South East Asia
        1. South East Asia In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. South East Asia In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. South East Asia In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. South East Asia In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Rest of Asia Pacific In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Rest of Asia Pacific In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Rest of Asia Pacific In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
  7. Latin America In vitro Diagnostics (IVD) Market - Segment Analysis
    1. Overview
    2. Latin America In vitro Diagnostics (IVD) Market, 2016 - 2028 (USD Million)
    3. Latin America In vitro Diagnostics (IVD) Market, by Products & Services
      1. By Reagents & Kits
      2. By Instruments
      3. By Services
      4. By Data Management Software
    4. Latin America In vitro Diagnostics (IVD) Market, by Technology
      1. By Immunoassay/ Immunochemistry
      2. By Clinical Chemistry
      3. By Molecular Diagnostics
      4. By Hematology
      5. By Microbiology
      6. By Coagulation & Hemostasis
      7. By Urinalysis
      8. By Other Technologies
    5. Latin America In vitro Diagnostics (IVD) Market, by Application
      1. By Infectious Diseases
      2. By Diabetes
      3. By Oncology
      4. By Cardiology
      5. By Drug Testing/ Pharmacogenomics
      6. By Autoimmune Diseases
      7. By HIV/AIDS
      8. By Nephrology
      9. By Other Applications
    6. Latin America In vitro Diagnostics (IVD) Market, by End User
      1. By Hospital Laboratories
      2. By Clinical Laboratories
      3. By Point-of-care Testing Centers
      4. By Academic Institutes
      5. By Patients
      6. By Other End Users
    7. Latin America In vitro Diagnostics (IVD) Market, by Country
      1. Brazil
        1. Brazil In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Brazil In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Brazil In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Brazil In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      2. Argentina
        1. Argentina In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Argentina In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Argentina In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Argentina In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      3. Rest of Latin America
        1. Rest of Latin America In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Rest of Latin America In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Rest of Latin America In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Rest of Latin America In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
  8. Middle East & Africa In vitro Diagnostics (IVD) Market - Segment Analysis
    1. Overview
    2. Middle East & Africa In vitro Diagnostics (IVD) Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa In vitro Diagnostics (IVD) Market, by Products & Services
      1. By Reagents & Kits
      2. By Instruments
      3. By Services
      4. By Data Management Software
    4. Middle East & Africa In vitro Diagnostics (IVD) Market, by Technology
      1. By Immunoassay/ Immunochemistry
      2. By Clinical Chemistry
      3. By Molecular Diagnostics
      4. By Hematology
      5. By Microbiology
      6. By Coagulation & Hemostasis
      7. By Urinalysis
      8. By Other Technologies
    5. Middle East & Africa In vitro Diagnostics (IVD) Market, by Application
      1. By Infectious Diseases
      2. By Diabetes
      3. By Oncology
      4. By Cardiology
      5. By Drug Testing/ Pharmacogenomics
      6. By Autoimmune Diseases
      7. By HIV/AIDS
      8. By Nephrology
      9. By Other Applications
    6. Middle East & Africa In vitro Diagnostics (IVD) Market, by End User
      1. By Hospital Laboratories
      2. By Clinical Laboratories
      3. By Point-of-care Testing Centers
      4. By Academic Institutes
      5. By Patients
      6. By Other End Users
    7. Middle East & Africa In vitro Diagnostics (IVD) Market, by Country
      1. GCC Countries
        1. GCC Countries In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. GCC Countries In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. GCC Countries In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. GCC Countries In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      2. South Africa
        1. South Africa In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. South Africa In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. South Africa In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. South Africa In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa In vitro Diagnostics (IVD) Market, By Products & Services
          1. By Reagents & Kits
          2. By Instruments
          3. By Services
          4. By Data Management Software
        2. Rest of Middle East & Africa In vitro Diagnostics (IVD) Market, By Technology
          1. By Immunoassay/ Immunochemistry
          2. By Clinical Chemistry
          3. By Molecular Diagnostics
          4. By Hematology
          5. By Microbiology
          6. By Coagulation & Hemostasis
          7. By Urinalysis
          8. By Other Technologies
        3. Rest of Middle East & Africa In vitro Diagnostics (IVD) Market, By Application
          1. By Infectious Diseases
          2. By Diabetes
          3. By Oncology
          4. By Cardiology
          5. By Drug Testing/ Pharmacogenomics
          6. By Autoimmune Diseases
          7. By HIV/AIDS
          8. By Nephrology
          9. By Other Applications
        4. Rest of Middle East & Africa In vitro Diagnostics (IVD) Market, By End User
          1. By Hospital Laboratories
          2. By Clinical Laboratories
          3. By Point-of-care Testing Centers
          4. By Academic Institutes
          5. By Patients
          6. By Other End Users
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Roche Diagnostics (Switzerland)
    2. Siemens Healthineers (Germany)
    3. Danaher Corporation (US)
    4. Abbott (US)
    5. Thermo Fisher Scientific (US)
    6. Johnson & Johnson (US)
    7. Becton Dickinson & Company (US)
    8. Bio-Rad Laboratories (US)
    9. Sysmex Corporation (Japan)
    10. bioMérieux (France)
    11. DiaSorin (Italy)
    12. Ortho Clinical Diagnostics (US)
    13. QIAGEN N.V. (Netherlands)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 15-Dec-2022
“In vitro Diagnostics (IVD) Market to Reach Valuation of USD 141.1 Billion by 2028 –Rising Incidence of Chronic Diseases Drives the Market”
FAQ
Frequently Asked Question

  • The global In vitro Diagnostics (IVD) valued at USD 112.64 Billion in 2022 and is expected to reach USD 157.75 Billion in 2030 growing at a CAGR of 4.30%.

  • The prominent players in the market are Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton Dickinson & Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), QIAGEN N.V. (Netherlands).

  • The market is project to grow at a CAGR of 4.30% between 2023 and 2030.

  • The driving factors of the In vitro Diagnostics (IVD) include

    • Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases

  • North America was the leading regional segment of the In vitro Diagnostics (IVD) in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy